Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of inhaled Technosphere insulin versus subcutaneous prandial insulin in adults with diabetes and asthma
2005-004589-18Phase 3Completed
- Sponsor
- MannKind
- Start
- Jun 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in diabetes mellitus type 1 (T1D) and type 2 diabetes mellitus (T2DM) comparing Inhaled Technosphere insulin with Subcutaneous prandial insulin control (2 arms). Primary endpoint: Change from baseline to month 12 in post-bronchodilator FEV1. Started Jun 2006; status: completed.
02
Drugs
Technosphere insulinhuman insulin
03
Conditions
diabetes mellitus type 1 (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2005-004589-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004589-18.